Ajooni Biotech Limited — Important, 19-04-2025: General Updates

The Board of Directors of Ajooni Biotech Limited has approved the withdrawal of its application for "In-principle approval" for the issue and allotment of 5,00,00,000 convertible warrants at an issue price of Rs. 9/- on a preferential basis. This decision follows feedback from investors expressing a desire to retract the offer due to the current low market rates and lack of interest in the securities. The company has opted to prioritize current market conditions, impacting its immediate financing strategies and potentially influencing investor sentiment.